Kevin Davies is an author and Executive Editor at CRISPR Journal and GEN Biotechnology Journal, specializing in genome editing and CRISPR technology. He leads scientific publishing efforts and organizes genomics-focused events, collaborating with leading experts in the field. Based in Washington DC, Davies is recognized for his contributions to advancing biotechnology knowledge through editorial leadership and public engagement.

‌